The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Olmesartan/Hydrochlorothiazide Clonmel 20 mg/25 mg film-coated tablets

20 mg/25 milligram(s) Film-coated tablet

Clonmel Healthcare LtdPA0126/260/002

Main Information

Trade NameOlmesartan/Hydrochlorothiazide Clonmel 20 mg/25 mg film-coated tablets
Active SubstancesOlmesartan Medoxomil
Strength20 mg/25 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/260/002

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA08 olmesartan medoxomil and diuretics


Licence Issued20/05/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0106-163-003
Interchangeable List DocumentPDF of Interchangeable List
« Back